Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endocrine and Neuroendocrine Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03841110
What this trial is testing

FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsLymphomaGastric Cancer+15 more
Fate Therapeutics 37
Early research (Phase 1)Study completedNCT05800106
What this trial is testing

A Bioequivalence Study of Sunitinib Malate Capsules.

Who this might be right for
Gastrointestinal Stromal TumorsRenal Cell CarcinomaPancreatic Neuroendocrine Tumor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 24
Not applicableStudy completedNCT04483349
What this trial is testing

Assessment of What Patients and Healthcare Providers Value

Who this might be right for
Gastric AdenocarcinomaPancreatic AdenocarcinomaPancreatic Neuroendocrine Carcinoma
M.D. Anderson Cancer Center 397
Early research (Phase 1)Study completedNCT00844064
What this trial is testing

Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2

Who this might be right for
Pancreatic NeoplasmsMelanomaColorectal Neoplasms
Isarna Therapeutics GmbH 62
Not applicableEnded earlyNCT01348698
What this trial is testing

Evaluation of Molecular Markers in Adrenal Tumors

Who this might be right for
Adrenal Gland Neoplasms
National Cancer Institute (NCI) 74
Early research (Phase 1)Study completedNCT01300533
What this trial is testing

BIND-014 Given to Patients With Advanced or Metastatic Cancer

Who this might be right for
Metastatic CancerCancerSolid Tumors
BIND Therapeutics 58
Early research (Phase 1)Ended earlyNCT02576665
What this trial is testing

Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)

Who this might be right for
Colorectal CancerTriple Negative Breast CancerPancreatic Cancer+9 more
Tocagen Inc. 21
Testing effectiveness (Phase 2)Study completedNCT00333502
What this trial is testing

Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors

Who this might be right for
CancerSolid Tumor
NewLink Genetics Corporation 62
Not applicableUnknownNCT03417843
What this trial is testing

Safety and Efficacy of an Ablation Catheter for the Treatment of Pancreatic Premalignant Cyctic Lesions.

Who this might be right for
Pancreatic CancerPancreatic Neuroendocrine TumorPancreatic Cyst+1 more
HaEmek Medical Center, Israel 20
Testing effectiveness (Phase 2)Study completedNCT00003308
What this trial is testing

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

Who this might be right for
Kidney CancerMelanoma (Skin)Metastatic Cancer+2 more
Eastern Cooperative Oncology Group
Early research (Phase 1)Study completedNCT00667082
What this trial is testing

NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma

Who this might be right for
Non-Small Cell Lung CancerPancreatic CancerMelanoma+2 more
Celgene 22
Early research (Phase 1)Study completedNCT06108479
What this trial is testing

Study of DF6215 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultSolid Tumor Cancer
Dragonfly Therapeutics 35
Early research (Phase 1)UnknownNCT00986661
What this trial is testing

Assess PV-10 Chemoablation of Cancer of the Liver

Who this might be right for
Cancer Metastatic to the LiverHepatocellular CarcinomaMetastatic Melanoma+7 more
Provectus Biopharmaceuticals, Inc. 78
Early research (Phase 1)Looking for participantsNCT05746897
What this trial is testing

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

Who this might be right for
Ovarian CancerMelanomaTriple Negative Breast Cancer+1 more
Hefei TG ImmunoPharma Co., Ltd. 38
Very early researchUnknownNCT05180851
What this trial is testing

Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study

Who this might be right for
Head and Neck CancerMelanomaBreast Cancer+4 more
Shanghai Fengxian District Central Hospital 28
Testing effectiveness (Phase 2)Study completedNCT02230176
What this trial is testing

Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II

Who this might be right for
Pancreatic Neuroendocrine Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris 84
Not applicableActive Not RecruitingNCT07259304
What this trial is testing

Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+97 more
University of Southern California 118
Testing effectiveness (Phase 2)Active Not RecruitingNCT03891784
What this trial is testing

Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors

Who this might be right for
Advanced Digestive System Neuroendocrine NeoplasmDigestive System Neuroendocrine TumorForegut Neuroendocrine Tumor+6 more
University of Washington 20
Testing effectiveness (Phase 2)Study completedNCT03037385
What this trial is testing

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more
Hoffmann-La Roche 590
Not applicableUnknownNCT00757614
What this trial is testing

Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsEsophageal Cancer+6 more
Cancer Research UK 14,000
Next Page